Status:
COMPLETED
Promiseb Topical Cream for Cradle Cap
Lead Sponsor:
Promius Pharma, LLC
Conditions:
Cradle Cap
Infantile Seborrheic Dermatitis
Eligibility:
All Genders
30+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of Promiseb Topical Cream in cradle cap.
Eligibility Criteria
Inclusion
- Clinical diagnosis of cradle cap
- Must be at least 30 days old
- Must be in good health as determined by investigator
- Naive to prior cradle cap therapy (may have used mineral, olive oils)
Exclusion
- Known food, topical product or medicinal allergies.
- Prior use of corticosteroids, antifungals or keratolytics for Cradle Cap
- Weighing less than 7 lbs
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT01214434
Start Date
March 1 2010
End Date
June 1 2011
Last Update
March 7 2017
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Norwich Pediatric Group
Norwich, Connecticut, United States, 06360
2
Derm Research
Louisville, Kentucky, United States, 40217
3
UMDNJ
Newark, New Jersey, United States, 07101
4
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104